After the isoxazoline gold rush: Where will industry turn for next big antiparasitic windfall?

摘要

The antiparasitic space has been an active battleground for the animal health industry for many decades. It is the largest single product market in animal health and will undoubtedly remain a key growth driver over the coming years. Animal Pharm editor Joseph Harvey canvassed opinion from a range of thought leaders on opportunities and challenges in this key blockbuster market. The active pharmaceutical ingredients (APIs) in the product are sarolaner, moxidectin and pyrantel. Sarolaner is the API inZoetis' Simparica antiparasitic, which surpassed $100 million in turnover for the first time in 2018.